ToledoLab_VHIO retweeted
Esta semana hemos sabido que el primer estudio #IMMUNOMICSVHIO, codirigido por Rodrigo Toledo y Elena Garralda, demuestra que la biopsia líquida ultrasensible puede predecir y monitorizar la respuesta a la inmunoterapia en cánceres avanzados.
➡️ linke.to/IMMUNOMICSVHIO_Cast
#CAIMI #UITM
ToledoLab_VHIO retweeted
I also had the rare (and fun) opportunity to tell an author their work was going to be on the cover of an upcoming issue when I met @RToledoLab at #AACR25! 😊
The May issue of @CD_AACR is now online! The cover features work by Carlota Arenillas, @RToledoLab, et al. providing evidence of convergent genetic adaptation in hypoxic tumors and in high-altitude populations. Read this and much more here: aacrjournals.org/cancerdisco… @VHIO
ToledoLab_VHIO retweeted
Featured on the cover: Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes brnw.ch/21wSxEo
By Carlota Arenillas, @RToledoLab, and colleagues @VHIO
ToledoLab_VHIO retweeted
Now online in @CD_AACR: Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes - by Carlota Arenillas, @RToledoLab, and colleagues doi.org/10.1158/2159-8290.CD… @VHIO
ToledoLab_VHIO retweeted
Predictive Impact of mRNF43 in MSS mBRAFV600E mCRC Treated With Target Therapy or CTx
@JCOPO_ASCO
doi.org/10.1200/PO.23.00255
👉pMMR/MSS mBRAFV600E mCRC benefit from TT vs CT independently of RNF43 mutational
👉Nevertheless, intersting efficacy in mRNF43 pts...
@myESMO @OncoAlert
ToledoLab_VHIO retweeted
Enhorabuena‼️ @RToledoLab recibe una de las Ayudas para la Investigación de la @APheipas para investigar la utilidad de la biopsia líquida en un grupo de tumores raros.
➕ bit.ly/RToledoPHEiPAS-VHIO
ToledoLab_VHIO retweeted
Published in @GenomeMedicine, a study co-led by VHIO’s Rodrigo A. Toledo reports on the development of new liquid biopsy methodology that showed 30% increased sensitivity in detecting ctDNA in pts with #AdvancedPancreaticCancer.
➕ bit.ly/ACT-DiscoverVHIO
ToledoLab_VHIO retweeted
🚨The Vall d’Hebron Institute of #Oncology @VHIO has an #openposition for a Junior Group Leader keen to launch a #research lab in #hematooncology & #Immunotherapy
Check here and reach out if you have questions! 👉🏽vhio.net/2023/05/12/ref-48-2… #CARTcell #Immunology #CancerResearch
ToledoLab_VHIO retweeted
📢Hoy, el Dr. @EnriquedeAlava, coordinador del proyecto #Immune4ALL nos cuenta cuál es el objetivo principal del proyecto y qué resultados en salud se pretenden alcanzar. 🎯 @CIBER_ISCIII @CIBERONC @CIBERehd @CIBERER @CIBERBBN
ToledoLab_VHIO retweeted
🔔Today is THE DAY! Kick-off meeting del proyecto con sesión inaugural a cargo del IP de proyecto @EnriquedeAlava.
ToledoLab_VHIO retweeted
🗞 Publicados en @NatureMedicine los resultados de un estudio liderado por @elena_elez y Rodrigo A. Toledo que identifican un biomarcador de respuesta al tratamiento para el #cáncercolorrectal metastásico BRAF-V600E
➕ bit.ly/VHIO-BRAFV600E-Cast
ToledoLab_VHIO retweeted
#Pacientes | Investigadores de @VHIO descubren mutaciones en un gen que podría ayudar a seleccionar aquellos pacientes que responden al tratamiento para un #cáncer colorrectal metastásico consalud.es/pacientes/pacien…
ToledoLab_VHIO retweeted
🗞 Published in @NatureMedicine results of study led by VHIO’s @elena_elez and Rodrigo A. Toledo unveil a biomarker of response to therapy in pts with microsatellite stable, BRAFV 600E mutated #metastaticcolorectalcancer
➕ bit.ly/VHIO-BRAFV600E
